Seattle biotech companies are using AI to design new medical treatments, but scientists caution the tech holds enormous promise, but needs to stay grounded in reality. Read More
Three Seattle biotech companies are joining forces to support open-access development of protein folding and design software. The project, called… Read More
Science magazine has revealed its breakthrough of the year: Artificial intelligence discoveries that predict how proteins fold, forged by researchers… Read More
The news: Seattle-based protein engineering company Cyrus Biotechnology has raised $18 million and acquired Orthogonal Biologics, a spinout from the… Read More
Seattle-based Cyrus Biotechnology is entering a protein engineering collaboration with Boston-based Selecta Biosciences that could pull in up to $1.5… Read More
Seattle-based Cyrus Biotechnology says it’ll collaborate with the Broad Institute of MIT and Harvard on ways to optimize CRISPR gene-editing… Read More
